Phase 3
18 Years
N/A
Not Enrolling
Both
Anemia

Thank you

Trial Information


Inclusion Criteria:



- Body weight >/=99 lbs

- ECOG 0-2

- Anemia results from cancer, chemotherapy, radiotherapy or an association with
hormonal therapy or immunotherapy

- Screening hemoglobin level of

Type of Study:

Interventional

Study Design:

Primary Purpose: Treatment

Authority:

United States: Food and Drug Administration

Study ID:

CR010939

NCT ID:

NCT00083486

Start Date:

February 2004

Completion Date:

October 2004

Related Keywords:

  • Anemia
  • Anemia

Name

Location
Charleston Hematology Oncology Charleston, South Carolina  29403
Northeast Urology Research Concord, North Carolina  28025
Mid Ohio Oncology Hematology Columbus, Ohio  43213
Drexel University College of Medicine Philadelphia, Pennsylvania  19129
Heritage Physician Group-Oncology Hot Springs, Arkansas  71913
Spalding Oncology Services Griffin, Georgia  30224
Southern Illinois Hematology Centralia, Illinois  62801
BioLab Research Rockville, Maryland  20852
Slocum-Dickson Medical Group, PC New Hartford, New York  13413
Caroline Cancer Center Aiken, South Carolina  29403
Charleston Cancer Care Charleston, South Carolina  29406
Volunteer Research Group Knoxville, Tennessee  37920